Skip to main content


Correction to: What is known about the effects of exercise or training to reduce skeletal muscle impairments of patients with myotonic dystrophy type 1? A scoping review

The original article was published in BMC Musculoskeletal Disorders 2019 20:101

Correction to: BMC Musculoskelet Disord (2019) 20:101


An incorrect attribution of the first study regarding the effect of exercise in DM1 mouse models needs to be revised.

Main text

In this article, we cited Manta et al. 2019 [1] as the first study to publish about the effects of exercise in DM1 mouse models This was an oversight considering that Ravel-Chapuis et al. 2018 [2] have reported in the last part of their “Results” section, presentation of the effects of wheel running on skeletal muscles of their DM1 mouse model. This article was published in October 2018 while the article of Manta et al. 2019 [1] was published in January 2019.


  1. 1.

    Manta A, Stouth DW, Xhuti D, Chi L, Rebalka IA, Kalmar JM, et al. Chronic exercise mitigates disease mechanisms and improves muscle function in myotonic dystrophy type 1 mice. J Physiol. 2019;597(5):1361–81.

  2. 2.

    Ravel-Chapuis A, Al-Rewashdy A, Belanger G, Jasmin BJ. Pharmacological and physiological activation of AMPK improves the spliceopathy in DM1 mouse muscles. Hum Mol Genet. 2018;27(19):3361–76.

Download references

Author information

Correspondence to Elise Duchesne.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (, which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated.

Reprints and Permissions

About this article